D0X
Atlas Energy Corp., a biotechnology company, develops, produces, and sells plant derived ingredients for consumer care, food and beverage, and pharmaceutical products in the United States. The company has licensing and development partnership with Laurus Labs to develop and commercialize active pharmaceutical ingredients and other ingredients. The company was formerly known as Willow Biosciences … Read more
D0X (D0X) - Net Assets
Latest net assets as of September 2025: €27.96 Million EUR
Based on the latest financial reports, D0X (D0X) has net assets worth €27.96 Million EUR as of September 2025.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (€28.12 Million) and total liabilities (€164.00K). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | €27.96 Million |
| % of Total Assets | 99.42% |
| Annual Growth Rate | N/A |
| 5-Year Change | N/A |
| 10-Year Change | N/A |
| Growth Volatility | 28.52 |
D0X - Net Assets Trend (2021–2024)
This chart illustrates how D0X's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for D0X (2021–2024)
The table below shows the annual net assets of D0X from 2021 to 2024.
| Year | Net Assets | Change |
|---|---|---|
| 2024-12-31 | €-505.00K | -114.70% |
| 2023-12-31 | €3.44 Million | -79.02% |
| 2022-12-31 | €16.37 Million | -44.84% |
| 2021-12-31 | €29.68 Million | -- |
Equity Component Analysis
This analysis shows how different components contribute to D0X's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 3403200000.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (December 2024)
| Component | Amount | Percentage |
|---|---|---|
| Other Components | €127.37 Million | % |
| Total Equity | €-505.00K | 100.00% |
D0X Competitors by Market Cap
The table below lists competitors of D0X ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Taokaenoi Food & Marketing Public Company Limited
BK:TKN
|
$51.80 Million |
|
Yangarra Resources Ltd
PINK:YGRAF
|
$51.80 Million |
|
Los Andes Copper Ltd
OTCQX:LSANF
|
$51.80 Million |
|
Handok
KO:002390
|
$51.81 Million |
|
Amicogen Inc
KQ:092040
|
$51.79 Million |
|
Birlesim Muhendislik Isitma Sogutma Havalandirma Sanayi & Ticaret Sirketi AS
IS:BRLSM
|
$51.78 Million |
|
Auburn National Bancorporation Inc
NASDAQ:AUBN
|
$51.75 Million |
|
TROPHY GAMES DEV. DK-020
F:4H7
|
$51.74 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in D0X's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from 3,436,000 to -505,000, a change of -3,941,000 (-114.7%).
- Net loss of 6,189,000 reduced equity.
- New share issuances of 1,910,000 increased equity.
- Other factors increased equity by 338,000.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | €-6.19 Million | -1225.54% |
| Share Issuances | €1.91 Million | +378.22% |
| Other Changes | €338.00K | +66.93% |
| Total Change | €- | -114.70% |
Book Value vs Market Value Analysis
This analysis compares D0X's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2021-12-31 | €1.20 | €0.09 | x |
| 2022-12-31 | €0.66 | €0.09 | x |
| 2023-12-31 | €0.14 | €0.09 | x |
| 2024-12-31 | €-0.02 | €0.09 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently D0X utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 0.00%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -132.75%
- • Asset Turnover: 1.87x
- • Equity Multiplier: 0.00x
- Recent ROE (0.00%) is above the historical average (-122.59%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2021 | -20.69% | -4616.54% | 0.00x | 1.18x | €-9.11 Million |
| 2022 | -90.47% | -1804.38% | 0.05x | 1.11x | €-16.45 Million |
| 2023 | -379.19% | -1111.69% | 0.18x | 1.94x | €-13.37 Million |
| 2024 | 0.00% | -132.75% | 1.87x | 0.00x | €-6.14 Million |
Industry Comparison
This section compares D0X's net assets metrics with peer companies in the Oil & Gas Midstream industry.
Industry Context
- Industry: Oil & Gas Midstream
- Average net assets among peers: $3,019,441,918
- Average return on equity (ROE) among peers: -4876.72%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| D0X (D0X) | €27.96 Million | -20.69% | 0.01x | $51.79 Million |
| HENGYANG PETROCHEM (5HY.SG) (5HY) | $571.85 Million | 3.31% | 0.00x | $3.68 Million |
| Byhmgard AB (publ) (EF8) | $402.00K | -29235.07% | 73.37x | $150.40 |
| MARATHON RESOURCES (LVT) | $73.02 Million | -7.67% | 0.77x | $42.18 Million |
| Sinopec Kantons Holdings Limited (SAK) | $15.40 Billion | 6.82% | 0.03x | $453.50 Million |
| Royal Vopak N.V (VPK5) | $1.93 Billion | 16.52% | 1.50x | $2.80 Billion |
| AB Klaipedos nafta (XIC) | $144.71 Million | -44.23% | 2.95x | $26.14 Million |